E-LIB Suche - Ergebnisse für: Muzio, V.

1

CUBAN VACCINES ABDALA AND MAMBISA AGAINST COVID-19:

Guillen, G. ; Limonta, M. ; Muzio, V....
International Journal of Infectious Diseases. 130 (2023) - p. S9-S10 , 2023

Link: https://doi.org/10.1016/..

2

HEPATITIS B NUCLEOCAPSID PARTICLE AS IMMUNOPOTENTIATOR OF I..:

Guillen, G. ; Limonta, M. ; Muzio, V....
International Journal of Infectious Diseases. 130 (2023) - p. S10 , 2023

Link: https://doi.org/10.1016/..

3

HeberNasvac: Novel therapeutic vaccine against chronic hepa..:

Guillen, G. ; Julio, A. ; Penton, E....
Journal of Hepatology. 68 (2018) - p. S523 , 2018

Link: https://doi.org/10.1016/..

4

PDB70 - ECONOMIC EVALUATION OF THE USE OF RECOMBINANT HUMAN..:

Muzio, V. ; Gonzalez, O. ; Garcia, D....
Value in Health. 21 (2018) - p. S130 , 2018

Link: https://doi.org/10.1016/..

5

Virus-like particles as nanovaccine candidates:

Guillen, G ; Aguilar, J C ; Dueñas, S...
Advances in Natural Sciences: Nanoscience and Nanotechnology. 4 (2013) 1 - p. 015005 , 2013

Link: https://doi.org/10.1088/..

6

Virus-Like Particles as vaccine antigens and adjuvants: app..:

Guillén, G. ; Aguilar, J.C. ; Dueñas, S....
Procedia in Vaccinology. 2 (2010) 2 - p. 128-133 , 2010

Link: https://doi.org/10.1016/..

7

Variable effects of cyclophosphamide in rodent models of ex..:

Mangano, K ; Nicoletti, A ; Patti, F...
Clinical and Experimental Immunology. 159 (2009) 2 - p. 159-168 , 2009

Link: https://doi.org/10.1111/..

8

Post-Marketing Surveillance of the Adverse Events Following..:

Muzio, V. ; Aguilar, A. ; Veliz, G....
International Journal of Infectious Diseases. 12 (2008) - p. e143 , 2008

Link: https://doi.org/10.1016/..

9

Comparative study of the immunogenicity and immunoenhancing..:

Lobaina, Y. ; Palenzuela, D. ; García, D....
Vaccine. 24 (2006) - p. S58-S59 , 2006

Link: https://doi.org/10.1016/..

10

P.339 A nasal vaccine candidate for chronic hepatitis B imm..:

Muzio, V.L. ; Aguilar, J.C. ; Aguilar, A....
Journal of Clinical Virology. 36 (2006) - p. S165 , 2006

Link: https://doi.org/10.1016/..

11

Immunological characterization of two hepatitis B core anti..:

LOBAINA, Y ; PALENZUELA, D ; PICHARDO, D...
Molecular Immunology. 42 (2005) 3 - p. 289-294 , 2005

Link: https://doi.org/10.1016/..

12

Development of a nasal vaccine for chronic hepatitis B infe..:

Aguilar, JC ; Lobaina, Y ; Muzio, V...
Immunology & Cell Biology. 82 (2004) 5 - p. 539-546 , 2004

Link: https://doi.org/10.1111/..

13

Mucosal immunogenicity of the hepatitis B core antigen:

Lobaina, Y ; Garcı́a, D ; Abreu, N..
Biochemical and Biophysical Research Communications. 300 (2003) 3 - p. 745-750 , 2003

Link: https://doi.org/10.1016/..

14

Acetyl-l-carnitine shows neuroprotective and neurotrophic a..:

Bigini, P ; Larini, S ; Pasquali, C..
Neuroscience Letters. 329 (2002) 3 - p. 334-338 , 2002

Link: https://doi.org/10.1016/..

15

Nitric oxide produced by non-motoneuron cells enhances rat ..:

Comoletti, D ; Muzio, V ; Capobianco, A..
Journal of the Neurological Sciences. 192 (2001) 1-2 - p. 61-69 , 2001

Link: https://doi.org/10.1016/..